Following a frozen embryo transfer, a procedure utilized in assisted reproductive technology, a diagnostic evaluation is conducted to ascertain whether implantation has occurred, resulting in a viable pregnancy. This evaluation typically involves measuring the levels of human chorionic gonadotropin (hCG), a hormone produced by the developing placenta, in either blood or urine. The timing of this assessment is crucial for accurate results.
The assessment provides essential information regarding the success of the transfer procedure, allowing for timely medical management. A positive result can lead to confirmation of pregnancy and subsequent prenatal care. Conversely, a negative outcome necessitates a review of the treatment protocol and consideration of future options. Historically, the development of sensitive and reliable methods for detecting early pregnancy has significantly improved the efficacy and patient experience in assisted reproductive technology.
